News
With the cost of the weight-loss jab set to rise by up to 170 per cent, Jade Kay, who has already spent £2,400 on the drug, says she will take a second job waitressing if she has to ...
Fat jabbers all over the country are in meltdown following the news that Mounjaro, the most popular and effective of all the ...
Novo Nordisk raced to meet demand for its weight-loss drug Wegovy and almost doubled its workforce over five years. Now, the ...
15h
Zacks Investment Research on MSNPost Obesity Pill Results Reveal: Buy, Sell or Hold VKTX Stock?
Shares of Viking Therapeutics VKTX plunged 36% in the past week after it reported mixed top-line results from a mid-stage study evaluating the safety and efficacy of the oral formulation of its ...
With the price of Mounjaro set to almost triple in the UK, there are fears more and more people will turn to counterfeits.
What goes up must come down — here are the major drugs falling the hardest at the top companies so far this year.
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.
From the makers of Mounjaro, it's creating a stir on social media ...
When bad news drops, investors have a tendency to sell first and ask questions later. Let's take a closer look at why Viking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results